// App-Quantinova.ai

: Is the strength of the type-2 (T2 inflammatory biomarker signal important in determining the burden of disease in severe asthma (SA?

Researchers

Presenter

  • Lauren Fox

Principal Investigators

  • Thomas Brown

  • Laura Wiffen

  • Thomas Jones

  • Kerry Gove

  • Clair Barber

  • Scott Elliott

  • Hitasha Rupani

  • Peter Howarth

  • Anoop Chauhan

Medical Centers

  • Portsmouth Hospital NHS Trust, Portsmouth, United Kingdom

  • University of Southampton, Southampten, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved